A sign is posted on the exterior of the AMC NewPark 12 theatre on August 23, 2022 in Newark, California. (Photo by Justin Sullivan/Getty Images)
Moviegoing at AMC theaters might be a bit more expensive — or cheaper — depending on where you want to sit.
The theater chain just announced its new Sightline program, featuring three different pricing tiers. The value section is made up of seats in the front rows, to be discounted.
The standard section, the most common ones, will remain traditionally priced, and preferred seats, typically the most prized ones in the middle of the auditorium, will charge a premium rate.
Moviegoers will get a detailed seating map with the different prices while purchasing on the web, through the AMC app, or at the box office.
Eliot Hamlisch, EVP and CMO of AMC Theaters, noted that it fits with the kind of changes that have already taken place in entertainment.
"Sightline at AMC more closely aligns with AMC's seat pricing approach to that of many other entertainment venues, offering experienced-based pricing and another way for moviegoers to find value at the movies," he said in a statement.
For those who might not be the biggest fans of the change, the Sightline program will only be in effect for films showing after 4 p.m. However, AMC noted that its goal is to expand the program to all of its locations, including its dine-in theaters, by the end of 2023.
The health and wellness industry is booming, expected to hit $14 trillion by 2032. Equinox teamed up with Function Health to revolutionize health optimization.
Featherie, a line of sustainable and functional golf wear for girls, fills a void in the market, catering to the increasing number of female junior golfers.
The CEO of LiveOne, Rob Ellin, discusses the DOJ's lawsuit against Live Nation and Ticketmaster, how will if affect you and the future of live events. Watch!
Nvidia did a record $26 billion in sales in the latest quarter. And get ready for the stock to keep climbing, because the A.I. boom is just getting started.
In honor of National Cancer Research Month, Perspective Therapeutics discusses its latest treatment — currently in clinical trials — that targets cancer cells d